爱游戏平台注册登录

Introducing Revvity - Expanding the boundaries of human potential through science

(Revvity was previously affiliated with 爱游戏平台注册登录 , Inc.)

We are now two standalone organizations

Life Sciences & Diagnostics and Analytical & Enterprise Solutions

Characterization of NISTmAb with Microfluidic CE-SDS

Application Note

Characterization of NISTmAb with Microfluidic CE-SDS using the Protein Clear HR Assay on the LabChip GXII Touch

Characterization of NISTmAb with Microfluidic CE-SDS

Introduction

Capillary electrophoresis (CE), more specifically CE-SDS, is becoming an increasingly popular and routinely used method for monitoring and documenting critical quality attributes for monoclonal antibody therapeutic products, due to its automated operation, on-column detection, great resolving power, and protein quantification capability. Such characterization is frequently used in the development and manufacture of biopharmaceutical products, to meet FDA documentation requirements.

The LabChip GXII Touch Biologics Characterization System features microfluidic CE-SDS (µCE-SDS) technology for analytical characterization of biopharmaceutical products. It offers an automated alternative to traditional SDS-PAGE methods, by streamlining the multiple, manual steps of slab gel electrophoresis, while providing the throughput and data quality essential to biotherapeutic workflows.

In this application note, the characterization of a reference monoclonal antibody from the National Institute of Standards and Technology (NIST) using the LabChip GXII Touch is compared to those published by NIST using the SCIEX® PA-800 Plus system.

Baidu
map